The trajectory of Viagra, originally marketed by copyright, presents a fascinating case study for investors considering the drug arena . Despite its groundbreaking success and impact of countless in earnings , the exclusivity end has opened the door for generic medications, greatly eroding income potential . This change raises doubts about the long